Cohance Lifesciences
NSEI:COHANCE
Rp 306,15
Rp0,00 (0,00%)
306,15 Rp
Rp0,00 (0,00%)
End-of-day quote: 03/27/2026

Quick Analysis
The traffic-light system summarizes key characteristics and shows the investment’s quality at a glance.

Rp10,45
Earnings Per Share
Rp68,23
Revenue Per Share
68,63%
Gross Margin %
Rp117,12 B
Market Cap
Rp0,06 B
Long-Term Debt
Earnings Per Share
Rp10,45
Revenue Per Share
Rp68,23
Gross Margin %
68,63%
Market Cap
Rp117,12 B
Long-Term Debt
Rp0,06 B

Financials

Year Year 2025 2024 2023 2022 2021 2020
EPS Earnings Per Share Rp10,45 Rp11,80 Rp16,16 Rp17,83 Rp14,23 Rp4,97
Earnings Earnings Rp4,00B Rp3,00B Rp4,11B Rp4,54B Rp3,62B Rp1,27B
RPS Revenue Per Share Rp68,23 Rp41,30 Rp52,65 Rp51,86 Rp39,67 Rp0,00
Revenue Revenue Rp26,10B Rp10,51B Rp13,40B Rp13,20B Rp10,10B Rp0,00M
OCF Operating Cash Flow Rp2,88B Rp3,58B Rp4,51B Rp3,30B Rp3,83B Rp0,00M
FCF Free Cash Flow Rp1,32B Rp0,00M Rp1,65B Rp2,55B Rp720,40M Rp0,00M
OM Operating Margin 27,40% 33,72% 38,71% 41,03% 40,59% 43,36%
GM % Gross Margin % 68,63% 57,17% 56,32% 56,51% 56,70% 59,69%
FCFS Free Cash Flow Per Share Rp5,20 Rp12,05 Rp6,49 Rp10,01 Rp10,71 Rp12,43
LT Debt Long-Term Debt Rp62,40M N/A Rp45,64M Rp284,40M Rp355,91M Rp912,53M
Sha. Stocks 382,57M 254,56M 254,56M 254,56M 254,56M 254,56M
×